Literature DB >> 24902923

Organizational and physician factors associated with patient enrollment in cancer clinical trials.

Sara R Jacobs1, Bryan J Weiner2, Bryce B Reeve3, Morris Weinberger4, Lori M Minasian5, Marjorie J Good5.   

Abstract

BACKGROUND: Our purpose was to identify physicians' individual characteristics, attitudes, and organizational contextual factors associated with higher enrollment of patients in cancer clinical trials among physician participants in the National Cancer Institute's Community Clinical Oncology Program (CCOP). We hypothesized that physicians' individual characteristics, such as age, medical specialty, tenure, CCOP organizational factors (i.e. policies and procedures to encourage enrollment), and attitudes toward participating in CCOP would directly determine enrollment. We also hypothesized that physicians' characteristics and CCOP organizational factors would influence physicians' attitudes toward participating in CCOP, which in turn would predict enrollment.
METHODS: We evaluated enrollment in National Cancer Institute-sponsored cancer clinical trials in 2011 among 481 physician participants using Structural Equation Modeling. The data sources include CCOP Annual Progress Reports, two surveys of CCOP administrators and physician participants, and the American Medical Association Masterfile.
RESULTS: Physicians with more positive attitudes toward participating in CCOP enrolled more patients than physicians with less positive attitudes. In addition, physicians who practiced in CCOPs that had more supportive policies and practices in place to encourage enrollment (i.e. offered trainings, provided support to screen and enroll patients, gave incentives to enroll patients, instituted minimum accrual expectations) also significantly enrolled more patients. Physician status as CCOP Principal Investigator had a positive direct effect on enrollment, while physician age and non-oncology medical specialty had negative direct effects on enrollment. Neither physicians' characteristics nor CCOP organizational factors indirectly influenced enrollment through an effect on physician attitudes.
CONCLUSION: We examined whether individual physicians' characteristics and attitudes, as well as CCOP organizational factors, influenced patient enrollment in cancer clinical trials among CCOP physicians. Physician attitudes and CCOP organizational factors had positive direct effects, but not indirect effects, on physician enrollment of patients. Our results could be used to develop physician-directed strategies aimed at increasing involvement in clinical research. For example, administrators may want to ensure physicians have access to support staff to help screen and enroll patients or institute minimum accrual expectations. Our results also highlight the importance of recruiting physicians for volunteer clinical research programs whose attitudes and values align with programmatic goals. Given that physician involvement is a key determinant of patient enrollment in clinical trials, these interventions could expand the overall number of patients involved in cancer research. These strategies will be increasingly important as the CCOP network continues to evolve.
© The Author(s) 2014.

Entities:  

Keywords:  Cancer; Community Clinical Oncology Program; National Cancer Institute Oncology Research Program; Structural Equation Modeling; clinical trial enrollment; organizational design features

Mesh:

Year:  2014        PMID: 24902923      PMCID: PMC4156916          DOI: 10.1177/1740774514536000

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  13 in total

1.  Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients.

Authors:  Halfdan Sorbye; Per Pfeiffer; Nina Cavalli-Björkman; Camilla Qvortrup; Mari H Holsen; Tore Wentzel-Larsen; Bengt Glimelius
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

2.  Sustainability and performance of the National Cancer Institute's Community Clinical Oncology Program.

Authors:  William R Carpenter; Alice K Fortune-Greeley; Leah L Zullig; Shoou-Yih Lee; Bryan J Weiner
Journal:  Contemp Clin Trials       Date:  2011-10-02       Impact factor: 2.226

3.  A population-based assessment of specialty physician involvement in cancer clinical trials.

Authors:  Carrie N Klabunde; Nancy L Keating; Arnold L Potosky; Anita Ambs; Yulei He; Mark C Hornbrook; Patricia A Ganz
Journal:  J Natl Cancer Inst       Date:  2011-02-11       Impact factor: 13.506

4.  Barriers and facilitators to enrollment in cancer clinical trials: qualitative study of the perspectives of clinical research associates.

Authors:  Eva Grunfeld; Louise Zitzelsberger; Marjorie Coristine; Faye Aspelund
Journal:  Cancer       Date:  2002-10-01       Impact factor: 6.860

5.  Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science.

Authors:  Laura J Damschroder; David C Aron; Rosalind E Keith; Susan R Kirsh; Jeffery A Alexander; Julie C Lowery
Journal:  Implement Sci       Date:  2009-08-07       Impact factor: 7.327

6.  Barriers to clinical trial participation as perceived by oncologists and patients.

Authors:  Neal J Meropol; Joanne S Buzaglo; Jennifer Millard; Nevena Damjanov; Suzanne M Miller; Caroline Ridgway; Eric A Ross; John D Sprandio; Perry Watts
Journal:  J Natl Compr Canc Netw       Date:  2007-09       Impact factor: 11.908

7.  Influence of clinical communication on patients' decision making on participation in clinical trials.

Authors:  Terrance L Albrecht; Susan S Eggly; Marci E J Gleason; Felicity W K Harper; Tanina S Foster; Amy M Peterson; Heather Orom; Louis A Penner; John C Ruckdeschel
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

Review 8.  Barriers to clinical trials. Part III: Knowledge and attitudes of health care providers.

Authors:  E G Mansour
Journal:  Cancer       Date:  1994-11-01       Impact factor: 6.860

9.  Accrual of patients to randomized clinical trials. Factors affecting cancer prevention and control research.

Authors:  A D Kaluzny; L M Lacey; R Warnecke; J P Morrissey; E J Sondik; L Ford
Journal:  Int J Technol Assess Health Care       Date:  1994       Impact factor: 2.188

10.  Predicting the performance of a strategic alliance: an analysis of the Community Clinical Oncology Program.

Authors:  A D Kaluzny; L M Lacey; R Warnecke; D M Hynes; J Morrissey; L Ford; E Sondik
Journal:  Health Serv Res       Date:  1993-06       Impact factor: 3.402

View more
  15 in total

1.  Science in the Heartland: Exploring determinants of offering cancer clinical trials in rural-serving community urology practices.

Authors:  Shellie D Ellis; Mugur Geana; Christine B Mackay; Deborah J Moon; Jessie Gills; Andrew Zganjar; Gayle Brekke; J Brantley Thrasher; Tomas L Griebling
Journal:  Urol Oncol       Date:  2019-03-29       Impact factor: 3.498

Review 2.  Barriers to accrual and enrollment in brain tumor trials.

Authors:  Eudocia Q Lee; Ugonma N Chukwueke; Shawn L Hervey-Jumper; John F de Groot; Jose Pablo Leone; Terri S Armstrong; Susan M Chang; David Arons; Kathy Oliver; Kay Verble; Al Musella; Nicole Willmarth; Brian M Alexander; Amanda Bates; Lisa Doherty; Evanthia Galanis; Sarah Gaffey; Thomas Halkin; Bret E Friday; Maryam Fouladi; Nancy U Lin; David Macdonald; Minesh P Mehta; Marta Penas-Prado; Michael A Vogelbaum; Solmaz Sahebjam; David Sandak; Martin van den Bent; Michael Weller; David A Reardon; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2019-09-06       Impact factor: 12.300

3.  The relationship between eligibility criteria and adverse events in randomized controlled trials of hematologic malignancies.

Authors:  A Statler; T Radivoyevitch; C Siebenaller; A T Gerds; M Kalaycio; E Kodish; S Mukherjee; C Cheng; M A Sekeres
Journal:  Leukemia       Date:  2016-12-07       Impact factor: 11.528

4.  Disparities in pediatric acute myeloid leukemia (AML) clinical trial enrollment.

Authors:  Lena E Winestone; Kelly D Getz; Pooja Rao; Yimei Li; Matt Hall; Yuan-Shung V Huang; Alix E Seif; Brian T Fisher; Richard Aplenc
Journal:  Leuk Lymphoma       Date:  2019-02-07

5.  Enrollment Trends and Disparity Among Patients With Lung Cancer in National Clinical Trials, 1990 to 2012.

Authors:  Herbert H Pang; Xiaofei Wang; Thomas E Stinchcombe; Melisa L Wong; Perry Cheng; Apar Kishor Ganti; Daniel J Sargent; Ying Zhang; Chen Hu; Sumithra J Mandrekar; Mary W Redman; Judith B Manola; Richard L Schilsky; Harvey J Cohen; Jeffrey D Bradley; Alex A Adjei; David Gandara; Suresh S Ramalingam; Everett E Vokes
Journal:  J Clin Oncol       Date:  2016-09-30       Impact factor: 44.544

6.  Incorporating Digital Tools to Improve Clinical Trial Infrastructure: A White Paper From the Digital Engagement Committee of SWOG.

Authors:  Don S Dizon; Mina S Sedrak; Mark A Lewis; Elise Cook; Michael J Fisch; Jennifer R Klemp; Jonathan Sommers; AnneMarie Ciccarella; Julie Gralow; Wendy Lawton; Craig Nichols
Journal:  JCO Clin Cancer Inform       Date:  2018-12

7.  Assessment of Karnofsky (KPS) and WHO (WHO-PS) performance scores in brain tumour patients: the role of clinician bias.

Authors:  D Frappaz; A Bonneville-Levard; D Ricard; S Carrie; C Schiffler; K Hoang Xuan; M Weller
Journal:  Support Care Cancer       Date:  2020-08-13       Impact factor: 3.603

8.  Barriers to participation in clinical trials: a physician survey.

Authors:  A Mahmud; O Zalay; A Springer; K Arts; E Eisenhauer
Journal:  Curr Oncol       Date:  2018-04-30       Impact factor: 3.677

9.  Will they participate? Predicting patients' response to clinical trial invitations in a pediatric emergency department.

Authors:  Yizhao Ni; Andrew F Beck; Regina Taylor; Jenna Dyas; Imre Solti; Jacqueline Grupp-Phelan; Judith W Dexheimer
Journal:  J Am Med Inform Assoc       Date:  2016-04-27       Impact factor: 4.497

10.  Understanding the Barriers to Pediatric Oncologist Engagement and Accrual to Clinical Trials in National Cancer Institute-Designated Community Oncology Research Programs.

Authors:  David S Dickens; Michael E Roth; Brad H Pollock; Anne-Marie Langevin
Journal:  JCO Oncol Pract       Date:  2020-05-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.